Literature DB >> 31054120

Dual versus triple therapy for patients with atrial fibrillation and acute coronary syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials.

Babikir Kheiri1, Mohammed Osman2, Ahmed Bakhit3, Qais Radaideh4, Ahmed Abdalla5, Mahmoud Barbarawi6, Yazan Zayed6, Sahar Ahmed6, Ghassan Bachuwa6, Mustafa Hassan7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31054120     DOI： 10.1007/s11239-019-01874-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  12 in total

1.  Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.

Authors:  Katrin A Fiedler; Michael Maeng; Julinda Mehilli; Stefanie Schulz-Schüpke; Robert A Byrne; Dirk Sibbing; Petra Hoppmann; Simon Schneider; Massimiliano Fusaro; Ilka Ott; Steen D Kristensen; Tareq Ibrahim; Steffen Massberg; Heribert Schunkert; Karl-Ludwig Laugwitz; Adnan Kastrati; Nikolaus Sarafoff
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

2.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2019-01-28       Impact factor: 24.094

3.  Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

Authors:  Renato D Lopes; Gretchen Heizer; Ronald Aronson; Amit N Vora; Tyler Massaro; Roxana Mehran; Shaun G Goodman; Stephan Windecker; Harald Darius; Jia Li; Oleg Averkov; M Cecilia Bahit; Otavio Berwanger; Andrzej Budaj; Ziad Hijazi; Alexander Parkhomenko; Peter Sinnaeve; Robert F Storey; Holger Thiele; Dragos Vinereanu; Christopher B Granger; John H Alexander
Journal:  N Engl J Med       Date:  2019-03-17       Impact factor: 91.245

4.  Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.

Authors:  Gerald Chi; Megan K Yee; Arzu Kalayci; Mathieu Kerneis; Fahad AlKhalfan; Roxana Mehran; Christoph Bode; Jonathan L Halperin; Freek W A Verheugt; Peter Wildgoose; Martin van Eickels; Gregory Y H Lip; Marc Cohen; Eric D Peterson; Keith A A Fox; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

5.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Authors:  Christopher P Cannon; Deepak L Bhatt; Jonas Oldgren; Gregory Y H Lip; Stephen G Ellis; Takeshi Kimura; Michael Maeng; Bela Merkely; Uwe Zeymer; Savion Gropper; Matias Nordaby; Eva Kleine; Ruth Harper; Jenny Manassie; James L Januzzi; Jurrien M Ten Berg; P Gabriel Steg; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

6.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Authors:  Willem J M Dewilde; Tom Oirbans; Freek W A Verheugt; Johannes C Kelder; Bart J G L De Smet; Jean-Paul Herrman; Tom Adriaenssens; Mathias Vrolix; Antonius A C M Heestermans; Marije M Vis; Jan G P Tijsen; Arnoud W van 't Hof; Jurriën M ten Berg
Journal:  Lancet       Date:  2013-02-13       Impact factor: 79.321

7.  2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).

Authors:  Gregory Y H Lip; Jean-Phillippe Collet; Michael Haude; Robert Byrne; Eugene H Chung; Laurent Fauchier; Sigrun Halvorsen; Dennis Lau; Nestor Lopez-Cabanillas; Maddalena Lettino; Francisco Marin; Israel Obel; Andrea Rubboli; Robert F Storey; Marco Valgimigli; Kurt Huber
Journal:  Europace       Date:  2019-02-01       Impact factor: 5.214

8.  Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.

Authors:  Charlotte H So; Mark H Eckman
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

Review 9.  Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma.

Authors:  Jung Rae Cho; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

10.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.

Authors:  C Michael Gibson; Roxana Mehran; Christoph Bode; Jonathan Halperin; Freek W Verheugt; Peter Wildgoose; Mary Birmingham; Juliana Ianus; Paul Burton; Martin van Eickels; Serge Korjian; Yazan Daaboul; Gregory Y H Lip; Marc Cohen; Steen Husted; Eric D Peterson; Keith A Fox
Journal:  N Engl J Med       Date:  2016-11-14       Impact factor: 91.245
View more
  2 in total

1.  Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal.

Authors:  Mattia Galli; Felicita Andreotti; Domenico D'Amario; Rocco Vergallo; Rocco A Montone; Giampaolo Niccoli; Filippo Crea
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-14

Review 2.  Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.

Authors:  Leonardo De Luca; Raffaella Mistrulli; Francesco Antonio Veneziano; Francesco Grigioni; Massimo Volpe; Francesco Musumeci; Domenico Gabrielli
Journal:  J Clin Med       Date:  2022-01-20       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.